PRUITT MICHAEL D (CEO, Chairman) purchased 6.9% of their position (1K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $1.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/31/2018ACC: 0001493152-18-018131
DirectorOfficer· CEO, Chairman
Since Aug 2018
+1K
Net shares
Net buyer
$1.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1K
Price / share
$1.30
Trade value
$1.30K
% of position
6.9%
12/31/2018
14.46K→15.46K
Total
Net shares
+1K
Net value
$1.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/31/2018 | P · Purchase | +1K | $1.30 | $1.30K | 6.9% | 14.46K | 15.46K |
| Total | +1K | $1.30K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
DirectShares owned17.26K
Common Stock
IndirectShares owned2.07K
Series 1 Preferred Stock
IndirectShares owned330.00
Total
17.26K direct·2.40K indirect19.66K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 17.26K | Direct |
| Common Stock | 2.07K | Indirect |
| Series 1 Preferred Stock | 330.00 | Indirect |
| Total | 19.66K | 17.26K direct·2.40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported